US Patent 10195150 Orally disintegrating tablet formulation for enhanced bioavailability
Patent 10195150 was granted and assigned to Kashiv Pharma Llc on February, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 7 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 26 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 5 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+229 characters)
Article
Patent abstract
In some aspects of the present invention is a formulation comprising a solid dispersion or intimate mixture of a poorly water soluble drug and an ionic polymer surprisingly exhibiting fast disintegration of tablet.
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
101951500
Date of Patent
February 5, 2019
0Patent Application Number
146530710
Date Filed
December 19, 2013
0Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
101951500
Date of Patent
February 5, 2019
0Patent Application Number
146530710
Date Filed
December 19, 2013
0Patent Primary Examiner
Edits on 24 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10195150 Orally disintegrating tablet formulation for enhanced bioavailability
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10195150
Date of patent
February 5, 2019
Patent application number
14653071
Date Filed
December 19, 2013
Patent primary examiner
Find more entities like US Patent 10195150 Orally disintegrating tablet formulation for enhanced bioavailability
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
